NYSE Euronext (NYX) today announced trading volumes for its
global derivatives and cash equities exchanges for April 20121.
Trading volumes were mixed both year-over-year and month-over-month
across most venues, but reflected some strengthening relative to
weak first quarter 2012 levels. Global derivatives average daily
volume (“ADV”) of 8.2 million contracts in April 2012 decreased
6.9% versus the prior year, but increased 1.4% from March 2012 and
increased 9.0% from first quarter 2012 levels. European cash
trading ADV in April increased 22.8% versus the prior year,
increased 14.8% from March 2012 levels and increased 17.8% from
first quarter 2012 levels. U.S. cash trading ADV decreased 13.3%
and 2.5% from April 2011 and March 2012 levels, respectively, and
declined 3.6% from first quarter 2012 levels.
Highlights
- NYSE Euronext global derivatives ADV in
April 2012 of 8.2 million contracts decreased 6.9% compared to
April 2011, but increased 1.4% from March 2012 levels and were up
9.0% from first quarter 2012 levels.
- NYSE Euronext European derivatives
products ADV in April 2012 of 4.3 million contracts decreased 9.6%
compared to April 2011, but increased 9.1% from March 2012 and were
up 28.2% from first quarter 2012 levels. Excluding Bclear, NYSE
Liffe's trade administration and clearing service for OTC products,
European derivatives products ADV decreased 2.8% compared to April
2011, were in-line with March 2012 and increased 5.3% from first
quarter 2012 levels.
- NYSE Euronext U.S. equity options ADV
of 3.9 million contracts in April 2012 decreased 3.3% compared to
April 2011 levels, decreased 4.9% from March 2012 and decreased
5.5% from first quarter 2012 levels. NYSE Euronext’s U.S. options
exchanges accounted for 26.4% of total U.S. consolidated equity
options trading in April 2012, up from 25.7% in April 2011 and up
from 26.0% in March 2012. NYSE Euronext was the #1 U.S. equity
options exchange operator in April 2012 and NYSE Amex Options
recorded record monthly market share of 15.8%.
- NYSE Liffe U.S. ADV of approximately
61,500 contracts decreased from 91,700 contracts in April 2011 and
decreased from 104,900 contracts in March 2012.
- NYSE Euronext European cash products
ADV of 1.9 million transactions in April 2012 increased 22.8%
compared to April 2011 and increased 14.8% from March 2012 levels.
European cash products ADV in April 2012 was 17.8% above first
quarter 2012 levels.
- NYSE Euronext U.S. cash products
handled ADV of 1.7 billion shares in April 2012 decreased 13.3%
compared to April 2011 and decreased 2.5% compared to March 2012.
U.S. cash products handled ADV in April 2012 was 3.6% below first
quarter 2012 levels. NYSE Euronext’s Tape A matched market share in
April 2012 was 31.3%, down from 33.3% in April 2011, in-line with
March 2012 and above the 30.6% recorded in the first quarter of
2012.
- There were a total of 19 trading days
in Europe and 20 trading days in the U.S. in April 2012 and April
2011.
Derivatives Trading
European Derivatives
- NYSE Euronext European derivatives
products ADV in April 2012 of 4.3 million contracts decreased 9.6%
compared to April 2011, but increased 9.1% from March 2012 levels
and was up 28.2% from first quarter 2012 levels.
- The 4.3 million in European derivatives
futures and options contracts ADV in April 2012 consisted of 2.8
million contracts executed through our full-service LIFFE CONNECT
trading platform and 1.5 million contracts, or 34.4%, executed
through Bclear, NYSE Liffe's trade administration and clearing
service for OTC products. Excluding Bclear, NYSE Liffe's trade
administration and clearing service for OTC products, European
derivatives products ADV decreased 2.8% compared to April 2011,
were in-line with March 2012 and increased 5.3% from first quarter
2012 levels.
- Year-to-date, European derivatives
products ADV of 3.5 million contracts was 23.8% below prior year
levels. The 3.5 million in futures and options contracts ADV
year-to-date consisted of 2.7 million contracts executed through
LIFFE CONNECT trading platform and 0.8 million contracts, or 24.1%,
executed through Bclear.
- Total fixed income products ADV of 1.8
million contracts in April 2012 decreased 7.1% from April 2011,
decreased 4.5% from March 2012, but were 1.0% above first quarter
2012 levels. Year-to-date, total fixed income products ADV of 1.8
million contracts was 29.5% below prior year levels.
- Total equity products (including
Bclear) ADV of 2.4 million contracts in April 2012 decreased 11.7%
compared to April 2011, but increased 22.6% from March 2012. The
2.4 million contracts in equity products ADV consisted of 1.8
million contracts in individual equity products ADV and 0.6 million
contracts in equity index products ADV. The 2.4 million contracts
in individual equity products ADV consisted of 1.3 million in
futures contracts, which represented a 24.6% decrease compared to
April 2011 and 0.5 million in options contracts, which represented
a 4.8% increase compared to April 2011. The average net rate per
contract for individual equity futures contracts is significantly
lower than other European derivatives products. Year-to-date, total
equity products ADV of 1.7 million contracts was 17.6% below prior
year levels.
- Total commodities products ADV of
approximately 81,000 contracts in April 2012 increased 4.7%
compared to April 2011 and decreased 1.2% compared to March 2012.
Year-to-date, total commodities product ADV of 81,000 contracts was
4.9% below prior year levels.
U.S. Derivatives
- NYSE Euronext U.S. equity options ADV
of 3.9 million contracts in April 2012 decreased 3.3% compared to
April 2011, decreased 4.9% compared to March 2012 and were 5.5%
below first quarter 2012 levels. Year-to-date, U.S. equity options
ADV of 4.1 million contracts was 5.7% below prior year levels.
- Total U.S. consolidated equity options
ADV decreased 5.9% to 14.8 million contracts in April 2012 compared
to April 2011 and decreased 6.6% compared to March 2012.
Year-to-date, U.S. consolidated equity options ADV of 15.6 million
contracts was 7.7% below prior year levels.
- NYSE Euronext’s U.S. options exchanges
accounted for 26.4% of the total U.S. consolidated equity options
trading in April 2012, up from 25.7% in April 2011 and up from
26.0% in March 2012. NYSE Euronext was the #1 U.S. equity options
exchange operator in April 2012 and NYSE Amex Options recorded
record monthly market share of 15.8%.
- NYSE Liffe U.S. ADV of approximately
61,500 contracts decreased from 91,700 contracts in April 2011 and
decreased from 104,900 contracts in March 2012. Year-to-date, U.S.
futures and futures options ADV of 87,700 contracts was 131.7%
above prior year levels.
Cash Trading
European Cash
- NYSE Euronext European cash products
ADV of 1.9 million transactions in April 2012 increased 22.8%
compared to April 2011, increased 14.8% compared to March 2012 and
was 17.8% above first quarter 2012 levels.
- Year-to-date, European cash products
ADV of 1.6 million transactions was 5.2% below prior year
levels.
U.S. Cash
- NYSE Euronext U.S. cash products
handled ADV in April 2012 decreased 13.3% to 1.7 billion shares
compared to April 2011, decreased 2.5% from March 2012 and was 3.6%
below first quarter 2012 levels.
- Year-to-date, U.S. cash products
handled ADV was 1.8 billion shares, down 20.7% from prior year
levels.
- NYSE Euronext’s Tape A matched market
share in April 2012 was 31.3%, down from 33.3% in April 2011,
in-line with March 2012 and above the 30.6% recorded in the first
quarter of 2012.
Exchange Traded Funds
- NYSE Euronext U.S. matched
exchange-traded funds ADV (included in volumes for Tape B and Tape
C) of 216 million shares in April 2012 decreased 10.6% compared to
April 2011, decreased 2.7% compared to March 2012 and decreased
2.3% compared to the first quarter of 2012.
- Year-to-date, NYSE Euronext U.S.
matched exchange-traded funds ADV of 220 million shares was 19.4%
below prior year levels.
Please click here for the Monthly Transaction Activity Data
Table.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial
markets and provider of innovative trading technologies. The
company's exchanges in Europe and the United States trade equities,
futures, options, fixed-income and exchange-traded products. With
approximately 8,000 listed issues (excluding European Structured
Products), NYSE Euronext's equities markets — the New York Stock
Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca —
represent one-third of the worlds equities trading, the most
liquidity of any global exchange group. NYSE Euronext also operates
NYSE Liffe, one of the leading European derivatives businesses and
the world's second-largest derivatives business by value of
trading. The company offers comprehensive commercial technology,
connectivity and market data products and services through NYSE
Technologies. NYSE Euronext is in the S&P 500 index. For more
information, please visit: www.nyx.com.
Disclaimer and Cautionary Note Regarding Forward-Looking
Statements
This press release may contain forward-looking statements,
including forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such
forward-looking statements include, but are not limited to,
statements concerning NYSE Euronext's plans, objectives,
expectations and intentions and other statements that are not
historical or current facts. Forward-looking statements are based
on NYSE Euronext's current expectations and involve risks and
uncertainties that could cause actual results to differ materially
from those expressed or implied in such forward-looking statements.
Factors that could cause NYSE Euronext's results to differ
materially from current expectations include, but are not limited
to: NYSE Euronext's ability to implement its strategic initiatives,
economic, political and market conditions and fluctuations,
government and industry regulation, interest rate risk and U.S. and
global competition, and other factors detailed in NYSE Euronext's
2011 Annual Report on Form 10-K and other periodic reports filed
with the U.S. Securities and Exchange Commission or the French
Autorité des Marchés Financiers. In addition, these statements are
based on a number of assumptions that are subject to change.
Accordingly, actual results may be materially higher or lower than
those projected. The inclusion of such projections herein should
not be regarded as a representation by NYSE Euronext that the
projections will prove to be correct. This press release speaks
only as of this date. NYSE Euronext disclaims any duty to update
the information herein.
1 All NYSE Euronext derivatives transactions count buy and sell
orders together as a single transaction. NYSE Euronext European
equities transactions count each buy and sell order as separate
transactions, NYSE Euronext U.S. equities transactions count buy
and sell orders together as a single transaction.
NYSE
Euronext
Monthly Volume
Summary
Average Daily Volume Total Volume
Average Daily Volume
Total Volume (Unaudited; contracts in
thousands)
Apr-12 Apr-11
% Chg Apr-12
Apr-11 % Chg YTD
2012
% Chg vs.
YTD 2011
YTD 2012
% Chg vs.
YTD 2011
Number of Trading Days - European Markets 19 19 19 19 84 84
Number of Trading Days - U.S. Markets 20 20 20 20 82 82
European Derivatives Products 4,270 4,721
-9.6% 81,127 89,699 -9.6% 3,544
-23.8% 297,722 -22.9% of which Bclear 1,471
1,842 -20.1% 27,945 34,990 -20.1% 853 -16.0% 71,675 -15.0%
Total Fixed Income Products 1,792 1,929
-7.1% 34,049 36,659 -7.1% 1,778
-29.5% 149,377 -28.7% Short Term
Interest Rate Products 1,665 1,817 -8.3% 31,636 34,516 -8.3% 1,632
-31.9% 137,074 -31.1% Medium and Long Term Interest Rate Products 1
127 113 12.7% 2,414 2,143 12.7% 146 15.1% 12,303 16.5%
Total Equity Products 2
2,397 2,714 -11.7% 45,538 51,570
-11.7% 1,685 -17.6% 141,512
-16.6% Individual Equity Products 1,847 2,254 -18.1%
35,085 42,828 -18.1% 1,206 -19.2% 101,328 -18.2% Futures 1,325
1,756 -24.6% 25,173 33,369 -24.6% 695 -17.8% 58,347 -16.8% Options
522 498 4.8% 9,913 9,459 4.8% 512 -20.9% 42,980 -20.0% Equity Index
Products 550 460 19.6% 10,453 8,742 19.6% 478 -13.4% 40,185 -12.3%
of which Bclear 1,471 1,842 -20.1% 27,945 34,990 -20.1% 853
-16.0% 71,675 -15.0% Individual Equity Products 1,409 1,785 -21.1%
26,765 33,914 -21.1% 783 -16.8% 65,763 -15.8% Futures 1,253 1,701
-26.3% 23,816 32,319 -26.3% 672 -18.8% 56,476 -17.9% Options 155 84
84.9% 2,948 1,594 84.9% 111 -1.4% 9,287 -0.2% Equity Index Products
62 57 9.7% 1,180 1,076 9.7% 70 -6.7% 5,912 -5.5%
Commodity Products 81 77 4.7%
1,539 1,470 4.7% 81 -4.9%
6,833 -3.7% U.S. Derivatives Products
Equity Options 3 NYSE Euronext Options
Contracts 3,903 4,034 -3.3% 78,050 80,687 -3.3% 4,073 -5.7% 333,973
-5.7% Total Consolidated Options Contracts 14,772 15,705 -5.9%
295,434 314,103 -5.9% 15,609 -7.7% 1,279,942 -7.7% NYSE
Group Share of Total 26.4% 25.7% 26.4% 25.7% 26.1% 0.6% 26.1% 0.6%
NYSE Liffe U.S. Futures and Futures Options
Volume* 61.5 91.7 -33.0% 1,291 1,834 -29.6% 87.7 131.7% 7,452.0
134.4%
European Cash Products (trades in thousands)
1,865 1,519 22.8% 35,444 28,860
22.8% 1,647 -5.2% 138,371 -4.1%
Equities 1,810 1,461 23.9% 34,385 27,757 23.9% 1,593 -4.6%
133,824 -3.4% Exchange-Traded Funds 16 16 -0.3% 301 302 -0.3% 15
-24.1% 1,242 -23.2% Structured Products 35 37 -5.7% 658 697 -5.7%
34 -19.9% 2,893 -19.0% Bonds 5 5 -3.0% 101 104 -3.0% 5 -9.9% 412
-8.8%
U.S. Cash Products (shares in millions)
5 1,719 1,982 -13.3% 34,378
39,637 -13.3% 1,768 -20.7%
144,935 -20.7% NYSE Listed (Tape A)
Issues 4 Handled Volume 5 1,238 1,409 -12.1%
24,760 28,179 -12.1% 1,266 -21.1% 103,782 -21.1% Matched Volume 6
1,170 1,330 -12.0% 23,408 26,610 -12.0% 1,194 -21.3% 97,939 -21.3%
Total NYSE Listed Consolidated Volume 3,743 3,995 -6.3% 74,868
79,902 -6.3% 3,886 -12.2% 318,667 -12.2%
Share of Total
Consolidated Volume Handled Volume 5 33.1% 35.3% -2.2% 33.1%
35.3% -2.2% 32.6% -3.7% 32.6% -3.7% Matched Volume 6 31.3% 33.3%
-2.0% 31.3% 33.3% -2.0% 30.7% -3.5% 30.7% -3.5%
NYSE Arca
& Amex (Tape B) Listed Issues Handled Volume 5 253
296 -14.5% 5,067 5,923 -14.5% 262 -21.5% 21,507 -21.5% Matched
Volume 6 226 265 -14.5% 4,530 5,295 -14.5% 234 -21.8% 19,200 -21.8%
Total NYSE Arca & Amex Listed Consolidated Volume 1,094 1,154
-5.2% 21,874 23,081 -5.2% 1,116 -14.4% 91,494 -14.4%
Share of Total Consolidated Volume Handled Volume 5 23.2%
25.7% -2.5% 23.2% 25.7% -2.5% 23.5% -2.2% 23.5% -2.2% Matched
Volume 6 20.7% 22.9% -2.2% 20.7% 22.9% -2.2% 21.0% -2.0% 21.0%
-2.0%
Nasdaq Listed (Tape C) Issues Handled
Volume 5 228 277 -17.8% 4,552 5,534 -17.8% 240 -17.6% 19,646 -17.6%
Matched Volume 6 192 234 -18.0% 3,832 4,672 -18.0% 203 -18.0%
16,608 -18.0% Total Nasdaq Listed Consolidated Volume 1,704 1,928
-11.6% 34,074 38,557 -11.6% 1,773 -12.3% 145,404 -12.3%
Share of Total Consolidated Volume Handled Volume 5 13.4%
14.4% -1.0% 13.4% 14.4% -1.0% 13.5% -0.9% 13.5% -0.9% Matched
Volume 6 11.2% 12.1% -0.9% 11.2% 12.1% -0.9% 11.4% -0.8% 11.4%
-0.8%
Exchange-Traded Funds 5,7 Handled
Volume 5 242 271 -10.5% 4,846 5,413 -10.5% 247 -18.9% 20,253 -18.9%
Matched Volume 6 216 242 -10.6% 4,327 4,838 -10.6% 220 -19.4%
18,045 -19.4% Total ETF Consolidated Volume 1,074 1,061 1.3% 21,487
21,216 1.3% 1,082 -9.9% 88,685 -9.9%
Share of Total
Consolidated Volume Handled Volume 5 22.6% 25.5% -2.9% 22.6%
25.5% -2.9% 22.8% -2.5% 22.8% -2.5% Matched Volume 6 20.1% 22.8%
-2.7% 20.1% 22.8% -2.7% 20.3% -2.4% 20.3% -2.4%
1 Data includes currency products.
2 Includes all trading activities for
Bclear, NYSE Liffe's clearing service for wholesale
derivatives.
3 Includes trading in U.S. equity options
contracts, not equity-index options.
4 Includes all volume executed in NYSE
Group crossing sessions.
5 Represents the total number of shares of
equity securities and ETFs internally matched on the NYSE Group's
exchanges or routed to and executed at an external market center.
NYSE Arca routing includes odd-lots.
6 Represents the total number of shares of
equity securities and ETFs executed on the NYSE Group's
exchanges.
7 Data included in previously identified
categories.
* ADVs calculated with the appropriate
number of NYSE Liffe U.S. trading days.
Source: NYSE Euronext, Options Clearing Corporation and
Consolidated Tape as reported for equity securities. All trading
activity is single-counted, except European cash trading which is
double counted to include both buys and sells. Please note: Nasdaq
Listed Consolidated Volumes have been adjusted for Nasdaq's April
5th UTDF trade reporting issue.
Grafico Azioni NYSE Group (NYSE:NYX)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni NYSE Group (NYSE:NYX)
Storico
Da Lug 2023 a Lug 2024